A modular platform for the rapid site-specific radiolabeling of proteins with 18F exemplified by quantitative positron emission tomography of human epidermal growth factor receptor 2.

作者: Herman S. Gill , Jeff N. Tinianow , Annie Ogasawara , Judith E. Flores , Alexander N. Vanderbilt

DOI: 10.1021/JM900420C

关键词:

摘要: Receptor-specific proteins produced by genetic engineering are attractive as PET imaging agents, but labeling with conventional (18)F-based prosthetic groups is problematic due to long synthesis times, poor radiochemical yields, and low specific activities. Therefore, we developed a modular platform for the rapid preparation of water-soluble capable efficiently introducing (18)F into proteins. The utility this demonstrated thiol-specific group, [(18)F]FPEGMA, which was used produce site-specifically (18)F-labeled protein ((18)F-trastuzumab-ThioFab) in 82 min total yield 13 +/- 3% activity 2.2 0.2 Ci/micromol. (18)F-trastuzumab-ThioFab retained biological native successfully validated vivo microPET Her2 expression xenograft tumor-bearing murine model modulated Hsp90 inhibitor, 17-(allylamino)-17-demethoxygeldanamycin.

参考文章(43)
Darell D. Bigner, Michael R. Zalutsky, Ganesan Vaidyanathan, Fluorine-18-labeled monoclonal antibody fragments: a potential approach for combining radioimmunoscintigraphy and positron emission tomography. The Journal of Nuclear Medicine. ,vol. 33, pp. 1535- 1541 ,(1992)
David B. Solit, Carlos Cordon-Cardo, David Verbel, Howard I. Scher, Brian Higgins, Neal Rosen, Pamela N. Münster, Fuzhong F. Zheng, David B. Agus, Maria Drobnjak, Glenn Heller, William Tong, 17-Allylamino-17-demethoxygeldanamycin Induces the Degradation of Androgen Receptor and HER-2/neu and Inhibits the Growth of Prostate Cancer Xenografts Clinical Cancer Research. ,vol. 8, pp. 986- 993 ,(2002)
Peter M. Smith-Jones, David Solit, Neal Rosen, Farzana Afroze, Steven M. Larson, Early Tumor Response to Hsp90 Therapy Using HER2 PET: Comparison with 18F-FDG PET The Journal of Nuclear Medicine. ,vol. 47, pp. 793- 796 ,(2006)
Christian W. Tornøe, Caspar Christensen, Morten Meldal, Peptidotriazoles on solid phase: [1,2,3]-triazoles by regiospecific copper(i)-catalyzed 1,3-dipolar cycloadditions of terminal alkynes to azides. Journal of Organic Chemistry. ,vol. 67, pp. 3057- 3064 ,(2002) , 10.1021/JO011148J
Lawrence E. Williams, Anna M. Wu, Paul J. Yazaki, An Liu, Andrew A. Raubitschek, John E. Shively, Jeffrey Y.C. Wong, Numerical Selection of Optimal Tumor Imaging Agents with Application to Engineered Antibodies Cancer Biotherapy and Radiopharmaceuticals. ,vol. 16, pp. 25- 35 ,(2001) , 10.1089/108497801750095989
Alan A Wilson, Li Jin, Armando Garcia, Jean N DaSilva, Sylvain Houle, An admonition when measuring the lipophilicity of radiotracers using counting techniques. Applied Radiation and Isotopes. ,vol. 54, pp. 203- 208 ,(2001) , 10.1016/S0969-8043(00)00269-4
Ganesan Vaidyanathan, Michael R. Zalutsky, Labeling proteins with fluorine-18 using N-succinimidyl 4-[18F]fluorobenzoate. International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology. ,vol. 19, pp. 275- 281 ,(1992) , 10.1016/0883-2897(92)90111-B
Philipp Holliger, Peter J Hudson, Engineered antibody fragments and the rise of single domains Nature Biotechnology. ,vol. 23, pp. 1126- 1136 ,(2005) , 10.1038/NBT1142
Jagath R. Junutula, Sunil Bhakta, Helga Raab, Karen E. Ervin, Charles Eigenbrot, Richard Vandlen, Richard H. Scheller, Henry B. Lowman, Rapid identification of reactive cysteine residues for site-specific labeling of antibody-Fabs Journal of Immunological Methods. ,vol. 332, pp. 41- 52 ,(2008) , 10.1016/J.JIM.2007.12.011